Avanos Medical (AVNS) Equity Average (2016 - 2024)
Historic Equity Average for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $1.2 billion.
- Avanos Medical's Equity Average fell 21.16% to $1.2 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $1.2 billion, marking a year-over-year decrease of 21.16%. This contributed to the annual value of $1.3 billion for FY2023, which is 133.89% down from last year.
- Latest data reveals that Avanos Medical reported Equity Average of $1.2 billion as of Q3 2024, which was down 21.16% from $1.2 billion recorded in Q2 2024.
- Avanos Medical's 5-year Equity Average high stood at $1.3 billion for Q1 2023, and its period low was $1.2 billion during Q2 2024.
- In the last 5 years, Avanos Medical's Equity Average had a median value of $1.3 billion in 2020 and averaged $1.3 billion.
- In the last 5 years, Avanos Medical's Equity Average skyrocketed by 248.51% in 2023 and then crashed by 485.35% in 2024.
- Over the past 5 years, Avanos Medical's Equity Average (Quarter) stood at $1.3 billion in 2020, then dropped by 0.76% to $1.3 billion in 2021, then increased by 0.88% to $1.3 billion in 2022, then dropped by 3.77% to $1.2 billion in 2023, then decreased by 0.27% to $1.2 billion in 2024.
- Its Equity Average stands at $1.2 billion for Q3 2024, versus $1.2 billion for Q2 2024 and $1.2 billion for Q1 2024.